Navican Genomics' Series A Round

Navican Genomics raised a round of funding on June 02, 2017. Investors include Intermountain Healthcare.

Navican provides a personalized approach to testing, diagnosing, and treating cancer. The company's unique process analyzes the genetic makeup of a patient's cancer and employs a team of skilled molec…

Articles about Navican Genomics' Series A Round: